Related Experiment Videos
Vascular tissue fragility assessed by a new double stain method
Masahiko Zuka1, Yasunori Okada, Ryoichi Nemori
1Department of Pathology and Division of Basic Science, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan. zukamas@scripps.edu
Summary
Matrix metalloproteinases (MMPs) are key in atherosclerosis. This study developed a new method to analyze MMP gelatinase activity in plaque tissues, revealing enhanced activity in superficial areas and altered MMP-2/MMP-9 levels with specific treatments.
Area of Science:
- Cardiovascular Biology
- Biochemistry
- Medical Diagnostics
Background:
- Matrix metalloproteinases (MMPs) play a role in atherosclerosis and plaque instability.
- Understanding MMPs' tissue-level functions is crucial for effective treatment strategies.
Purpose of the Study:
- To develop and validate a novel double staining method combining film in situ zymography and immunohistochemistry.
- To comprehensively analyze gelatinolytic activity within human atheromatous plaques at the tissue level.
Main Methods:
- Development of a novel double staining technique integrating film in situ zymography and immunohistochemistry.
- Application of the technique to analyze gelatinolytic activity in human atherosclerotic plaque tissues.
- Enzyme assays and gelatin zymography to quantify MMP activity and assess the impact of trapidil.
Main Results:
- Gelatinolytic activity was significantly enhanced in the shoulder region and fibrous cap of superficial atheromatous plaques.
- Enzyme assays confirmed high gelatinase activity in superficial plaque areas (7.50 ± 5.04 U/mg; P < 0.001).
- The antiplatelet agent, trapidil, was shown to modify the secretion and activation ratios of MMP-2 and MMP-9.
Conclusions:
- The novel technique provides a powerful tool for assessing gelatinase activity in resected human tissues.
- Findings highlight specific regions of enhanced MMP activity in atheromatous plaques, relevant to plaque stability.
- This approach may inform personalized treatment selection for patients with atherosclerosis.